Oral Infigratinib Therapy in Children with Achondroplasia
{{output}}
Background: Achondroplasia is a genetic skeletal condition that results in disproportionately short stature and medical complications throughout life. Infigratinib is an orally bioavailable FGFR1-3 selective tyrosine kinase inhib... ...